PACS Group Inc (PACS)
NYSE:PACS
Want to see PACS full AI Analyst Report?
Earnings Data
Report Date
Aug 17, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
0.53Last Year’s EPS
0.56Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call reported robust underlying operational and financial performance: double-digit revenue growth, a large increase in adjusted EBITDA and EPS, strong occupancy and improving skilled mix, demonstrable clinical quality gains, significant liquidity and capital allocation optionality. Key risks are unresolved government investigations, ongoing remediation of internal controls, unpredictability in quality-incentive payments (WQIP discontinuation), and ramp-related drag from new facilities. Management emphasized conservative guidance treatment for uncertain incentive payments and acquisitions while highlighting continued M&A pipeline activity and balance sheet flexibility.Company Guidance
Revenue Growth
Total revenue of $1.42 billion in Q1 2026, up ~11% year-over-year, with same-store revenue up 8% (same-store = 284 skilled nursing facilities in operation since 2025).
Strong Profitability and Margin Expansion
Net income of $80.7 million (up $52.3 million vs $28.5 million prior year, ~+183% YoY); adjusted EBITDA of $170 million (up $72.8 million, +75% YoY); adjusted EBITDAR of $266 million; diluted EPS $0.50 vs $0.17 prior year (increase of $0.33, ~+194%).
Operating Leverage
Cost of services rose to $1.07 billion (+5% YoY) while revenue grew ~11%, driving meaningful operating leverage; total operating expenses increased ~5.8% YoY despite continued investment in infrastructure and personnel.
Occupancy and Skilled Mix Improvements
Overall portfolio occupancy 90.9% (vs 89.2% prior year). Same-store occupancy improved from 89.6% to 90.8%. Skilled mix increased to 30.5%, up 90 basis points YoY. Mature facilities: 94.8% occupancy and 33% skilled mix; ramping facilities averaging 88.9% occupancy; new facilities averaging 82.7% occupancy with 26.5% skilled mix as they integrate.
Clinical Quality Progress
222 facilities rated 4- or 5-stars under CMS at quarter end (up from 207 a year earlier); mature-facility average CMS rating 4.4 vs industry average ~3.6 — demonstrating sustained clinical performance and improvement.
One-time / Program Benefits Recognized but Separately Disclosed
Included ~$16.3 million of net EBITDA benefit from California WQIP payments in adjusted EBITDA; excluding WQIP, adjusted EBITDA still increased by ~$57 million YoY in Q1 — management explicitly separating these payments from guidance due to timing uncertainty.
Strong Balance Sheet and Liquidity
Approximately $800 million of available liquidity at quarter end (including ~$250 million cash), net leverage ~0.1x; deployed $86.5 million in strategic real estate investments during the quarter.
Capital Allocation Optionality
Board approved a $250 million share repurchase authorization; management retains flexibility on pace and structure of buybacks and continues to pursue disciplined M&A pipeline.
Operating Model and Talent Development
Platform of 223 facilities across 17 states (~35,000 total beds, ~31.9k patients daily); continued focus on locally led, centrally supported model and leadership development (40 administrators-in-training) to support integration and scale.
Cash Generation
Reported cash from operating activities of $236 million in Q1; adjusted for a $50 million prepaid acquisition timing item, operating cash would still be ~$186 million — indicating strong cash generation relative to EBITDA.
PACS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
PACS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 11, 2026 | $31.90 | $41.01 | +28.56% |
Feb 26, 2026 | $41.67 | $36.51 | -12.38% |
Nov 19, 2025 | $16.83 | $26.14 | +55.32% |
Aug 18, 2025 | $11.50 | $11.41 | -0.78% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does PACS Group Inc (PACS) report earnings?
PACS Group Inc (PACS) is schdueled to report earning on Aug 17, 2026, After Close (Confirmed).
What is PACS Group Inc (PACS) earnings time?
PACS Group Inc (PACS) earnings time is at Aug 17, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PACS EPS forecast?
PACS EPS forecast for the fiscal quarter 2026 (Q2) is 0.53.